(Q48020260)

7 February 2018

title

Immunologic changes during immunotherapy in asthmatic children: increased IL-13 and allergen-specific IgG4 antibody levels. (English)

1 reference

7 February 2018

0 references

1 reference

Lu FM

1

1 reference

7 February 2018

Chou CC

series ordinal

2

1 reference

7 February 2018

Chiang BL

series ordinal

3

1 reference

7 February 2018

Hsieh KH

series ordinal

4

1 reference

7 February 2018

publication date

1 May 1998

1 reference

7 February 2018

Annals of Allergy, Asthma & Immunology

published in

1 reference

7 February 2018

volume

80

1 reference

7 February 2018

issue

5

1 reference

7 February 2018

page(s)

419-423

1 reference

7 February 2018

Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon-gamma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Allergen immunotherapy in asthma: evidence for efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Immune mechanisms in allergen-specific immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Immunological changes after hyposensitization in house-dust-sensitive asthmatic children: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

The effect of immunotherapy on interleukin-1 and tumor necrosis factor production of monocytes in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Altered production of histamine-releasing factor (HRF) activity and responsiveness to HRF after immunotherapy in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Changes of house dust mite-specific IgE, IgG and IgG subclass antibodies during immunotherapy in patients with perennial rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Immunotherapy suppresses the production of monocyte chemotactic and activating factor and augments the production of IL-8 in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Generation of Antigen-Specific Suppressor Cells during Allergy Desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Generation of suppressor cells in atopic patients during immunotherapy that modulate IgE synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Human TH1 and TH2 subsets: doubt no more

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Immunoregulatory properties of IL-13: its potential role in atopic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

Role of interleukin-4 and interleukin-13 in synthesis of IgE and expression of CD23 by human B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962995-X

7 January 2021

10.1016/S1081-1206(10)62995-X

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

9609614

1 reference

7 February 2018